Lexeo Therapeutics, Inc. Common Stock ( LXEO) - Key Metrics
LXEO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.30 | -$0.21 | -$0.21 |
| 2026Q1 | $0 | -$0.25 | -$0.26 | -$0.26 |
| 2025Q4 | $0 | -$0.27 | -$0.26 | -$0.26 |
| 2025Q3 | $0 | -$0.33 | -$0.48 | -$0.49 |
| 2025Q2 | $0 | -$0.60 | -$0.62 | -$0.63 |
LXEO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.88 |
| 2026Q1 | 0% | -5.74 |
| 2025Q4 | 0% | -9.19 |
| 2025Q3 | 0% | -5.03 |
| 2025Q2 | 0% | -1.67 |
LXEO
Price: $5.06
52 week price:
Earnings Per Share: -0.88 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 440.6 million